43 results
PRE 14A
mj6c sqhnbok1
19 Oct 23
Preliminary proxy
5:18pm
8-K
EX-10.1
v74 5x4vk8y7yp
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
1vcgtyy1 3i8fij
28 Sep 23
Departure of Directors or Certain Officers
6:17pm
DEFR14A
5awz78 80l2
25 Oct 22
Revised proxy
5:27pm
8-K
EX-3.1
367mglce 9yygq622o
13 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
D
z4hat
7 Oct 22
$16.19 mm in equity / options / securities to be acquired, sold $6.65 mm, 5 investors
5:32pm
8-K
EX-4.1
91yc pozdbr2l
29 Sep 22
Anebulo Pharmaceuticals Announces $6.6 million Private Placement Financing
4:05pm
8-K
EX-10.1
p2csier p8
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm